Efficacy and Tolerability of Sequential Intravenous/Oral Moxifloxacin Therapy in Pneumonia: Results of the First Post-Marketing Surveillance Study with Intravenous Moxifloxacin in Hospital Practice

By Barth J.  

Clinical Drug Investigation, Vol. 25, Iss. 11, 2005-01 ,pp. : 691-700

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Moxifloxacin in Patients with Respiratory Tract Infections Treated in General Practice: Results of a Post-Marketing Surveillance Study

By Chen Weiqiang   Wu Changgui   Li Zhikui   Bai Changqing  

Clinical Drug Investigation, Vol. 26, Iss. 9, 2006-01 ,pp. : 501-509

Adis International

Access to resources Recommend Favorite

Once-Daily Moxifloxacin Therapy for Community-Acquired Pneumonia in General Practice: Evidence from a Post-Marketing Surveillance Study of 1467 Patients

By H. Koch  

Clinical Drug Investigation, Vol. 24, Iss. 8, 2004-01 ,pp. : 441-448

Adis International

Access to resources Recommend Favorite

Post-Marketing Surveillance of Levofloxacin 0.5% Ophthalmic Solution for External Ocular Infections

By Kanda Yoshiko  

Drugs in R&D, Vol. 12, Iss. 4, 2012-12 ,pp. : 177-185

Adis International

Access to resources Recommend Favorite

The Real-life Safety and Efficacy of Vardenafil: an International Post-marketing Surveillance Study – Results from 29 358 German Patients

By van Ahlen H   Zumbé J   Stauch K   Landen H  

The Journal of International Medical Research, Vol. 33, Iss. 3, 2005-05 ,pp. : 337-348

Field House Publishing

Access to resources Recommend Favorite